Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
Machine scores (provisional)
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
- Teacher spread
- 0.323 · how far apart the two teachers sit on this one work
- Validation status
score_only:v0-immature-baseline· verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it
Abstract
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Journal of the National Comprehensive Cancer Network
- Topic
- Glioma Diagnosis and Treatment
- Field
- Medicine
- Canadian institutions
- —
- Funders
- AbbVie CanadaGenentechBayer HealthCareBoston PharmaceuticalsAgios PharmaceuticalsSK Life ScienceArbor PharmaceuticalsAstraZenecaCancer Research InstituteNovocureNational Comprehensive Cancer NetworkIpsenTakeda Pharmaceuticals North AmericaJazz PharmaceuticalsNational Institutes of HealthRegeneron PharmaceuticalsBeiGeneVarian Medical SystemsKaryopharm TherapeuticsUniversity of PennsylvaniaNational Cancer InstituteGilead SciencesINOVIO PharmaceuticalsNovartis Pharmaceuticals CorporationNational Cancer Research InstituteBristol-Myers SquibbJohns Hopkins UniversityAmgen
- Keywords
- MedicineCentral nervous systemRadiation therapyClinical PracticeOncologyRadiation oncologyDiseaseInternal medicinePathologyFamily medicine
- Has abstract in OpenAlex
- yes